bucladesine has been researched along with teleocidin b-4 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, Y; Kaneko, Y; Kariya, T; Kume, S; Oda, T; Ohashi, T; Tanabe, A; Yamanaka, M | 1 |
1 other study(ies) available for bucladesine and teleocidin b-4
Article | Year |
---|---|
Teleocidin, a tumor promoter, is a potent platelet-aggregating agent.
Topics: Alkaloids; Alprostadil; Blood Platelets; Bucladesine; Dose-Response Relationship, Drug; Edetic Acid; Humans; Kinetics; Lyngbya Toxins; Platelet Aggregation; Prostaglandins E; Serotonin; Theophylline | 1981 |